Targeted drug found effective in patients who have lung cancer with certain mutations
Tuesday, September 8, 2020 - 16:30
in Health & Medicine
A targeted therapy called capmatinib can provide significant benefits to patients who have advanced lung cancer with specific gene mutations, according to recently published results from a phase two clinical trial.